Expedite time to market with the fastest and easiest IgG quantification assay in the industry
The ability to reliably monitor protein titer in real time throughout a bioprocess allows operators to rapidly adjust the process conditions for maximum protein output while minimizing process time. Quick access to titer data also enables earlier decisions regarding preparation of downstream processes, further reducing the production timeline.
Integrating ValitaTiter and Molecular Devices fluorescence polarization (FP) plate readers produces a seamless IgG titer assay setup and optimization. Cell line development teams will realize savings on time and resources, as well as faster time-to-market by utilizing a single technology for measuring a critical quality attribute during target selection, process development, and production QC.
Producing rapid results compared to HPLC, ELISA, and biolayer interferometry, ValitaTiter is the most efficient assay for minimizing costs and time to results because it works in the presence of cells, minimizes dilutions, eliminates wash steps, and easily integrates into (automated) high-throughput cell line development (CLD) workflows.
Valita and Valita Titer are trademarks of ValitaCell in certain jurisdictions
Order now to receive a 13% discount on a 40 pack of ValitaTiter plates
- 4x Faster than existing methods: Fast, homogeneous, and automation-friendly assay with results for 96 samples in less than 15 minutes
- Expedite time to market: Reliably monitor protein titer in real-time throughout the bioprocess to rapidly adjust the process conditions for maximum protein output while minimizing process time.
- Reduce development risk: Measure and monitor human IgG production at multiple time points to ensure quality and reduce development risk.
- Save on a bundle
Latest Resources
Resources of Rapid, high-throughput IgG quantification with ValitaTiter
Data Sheet
Valita®Titer Plus Materials Safety Statement
Valita®Titer Plus Materials Safety Statement
All working solutions for the intermediate Valita®Titer Plus plate product (Cat. No.VAL004), are not classified as hazardous materials by the current state of scientific knowledge.
-
Data Sheet
Valita®Titer Materials Safety Statement
Valita®Titer Materials Safety Statement
All working solutions for the intermediate Valita®Titer plate product (Cat. No. VAL003), are not classified as hazardous materials by the current state of scientific knowledge.
Flyer
Quickly and easily quantify IgG with ValitaTiter
Quickly and easily quantify IgG with ValitaTiter
Integrating ValitaTiter and Molecular Devices fluorescence polarization (FP) plate readers produces a seamless IgG titer assay setup and optimization. Cell line development teams will r…
Scientific Poster
High-throughput IgG quantitation platform for clone screening during drug discovery and development
High-throughput IgG quantitation platform for clone screening during drug discovery and development
Biologic drugs are the largest and fastest growing segment of the pharmaceutical industry with sales of €500bn and an annual growth of 8%. Every manufacturing process for potential b…
Application Note
High-throughput IgG quantitation platform for clone screening during drug discovery and development
High-throughput IgG quantitation platform for clone screening during drug discovery and development
Biologic drugs are the largest and fastest growing segment of the pharmaceutical industry with sales of €500bn and an annual growth of 8%. Every manufacturing process for potential…
High-throughput IgG quantitation platform for clone screening during drug discovery and development
Related Products & Services of Rapid, high-throughput IgG quantification with ValitaTiter
How can we help advance your next big discovery?
Our highly-qualified teams are on the frontlines with our customers, conducting remote or on-site product demonstrations, webinars, and more to help you solve your tough research challenges. How can we help you today?
I’d like to…